A Double Blind Placebo Controlled Study of Valaciclovir in Treatment of Psychosis in Patients With Schizophrenia.
Phase of Trial: Phase II
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Valaciclovir (Primary)
- Indications Psychotic disorders; Schizophrenia
- Focus Biomarker; Therapeutic Use
- 30 Nov 2016 Status changed from recruiting to completed.
- 17 Feb 2015 Planned End Date changed from 1 Jul 2013 to 1 Jan 2016 as reported by ClinicalTrials.gov.
- 17 Feb 2015 Planned primary completion date changed from 1 Aug 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.